According to market sources, Wipro BPO is likely to buyout MarketRx, a pharma focused market analytics company. If put through this acquisition will bolster Wipro BPO’s analytics practice, which at present accounts for less than 10% of its revenues. marketRx, has declined to confirm that it was in talks with specific companies, but has made it clear that since the analytics space has generated lot of interest if they get a good offer they would consider it. The New Jersey-headquartered $50-million marketRx has over 25 clients, including Merck, Eli Lilly, Pfizer and Johnson & Johnson. It has offices in Gurgaon, Europe and the US. Gurgaon is its largest centre with 250 of its 400 staff working here. The market analytics company provides solutions in sales and marketing tracking, analysis, planning and optimisation as well as market research and interactive marketing services for pharma companies.